Suchergebnisse - "Babiker, Hani M"

PubPharm (93)

51

Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)

enthalten in: Expert opinion on investigational drugs | 2019

von Babiker, H. | Karass, M. | Recio-Boiles, A. | +3

52

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations

enthalten in: Expert opinion on investigational drugs | 2019

von Babiker, H. | Davis, L. | Larson, K. | +14

53

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

enthalten in: JAMA dermatology | 2019

von Almutairi, A. | Alkhatib, N. | Oh, M. | +5

CommentIn: JAMA Dermatol. 2019 Jan 1;155(1):15-16. - PMID 30476974

54

The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality : A meta‐analysis

enthalten in: The Prostate | 2019

von Oh, M. | Alkhushaym, N. | Fallatah, S. | +8

55

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

enthalten in: Investigational new drugs | 2018

von Babiker, H. | Byron, S. | Hendricks, W. | +20

56

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

enthalten in: Investigational new drugs | 2018

von Babiker, H. | Byron, S. | Hendricks, W. | +20

57

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

enthalten in: Investigational new drugs | 2018

von Babiker, H. | Byron, S. | Hendricks, W. | +20

58

Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting

enthalten in: Drugs - real world outcomes | 2018

von Cartwright, T. | Parisi, M. | Espirito, J. | +4

59

Exploring the role of oncolytic viruses in hepatobiliary cancers

enthalten in: Immunotherapy | 2018

von Tenneti, P. | Borad, M. | Babiker, H.

60

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

enthalten in: The New England journal of medicine | 2018

von Migden, M. | Rischin, D. | Schmults, C. | +34

CommentIn: Nat Rev Clin Oncol. 2018 Aug;15(8):472. - PMID 29921845